Benchmark Wealth Management, LLC Pfizer Inc Transaction History

Benchmark Wealth Management, LLC

$206 Million
Q1 2025

A detailed history of Benchmark Wealth Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Benchmark Wealth Management, LLC holds 14,738 shares of PFE stock, worth $326,299. This represents 0.18% of its overall portfolio holdings.

Number of Shares

14,738

Previous 16,838 12.47%

Holding current value

$326,299

Previous $446,000 16.37%

% of portfolio

0.18%

Previous 0.22%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 07, 2025	SELL	$25.01 - $27.13 $52,521 - $56,973	-2,100 Reduced 12.47%	14,738 $373,000
Q4 2024 Jan 07, 2025	SELL	$24.8 - $30.19 $8,531 - $10,385	-344 Reduced 2.0%	16,838 $446,000
Q3 2024 Oct 18, 2024	SELL	$27.7 - $31.39 $22,160 - $25,112	-800 Reduced 4.45%	17,182 $497,000
Q2 2024 Jul 08, 2024	SELL	$25.26 - $29.6 $38,572 - $45,199	-1,527 Reduced 7.83%	17,982 $503,000
Q4 2023 Jan 19, 2024	SELL	$26.13 - $33.94 $197,412 - $256,416	-7,555 Reduced 27.92%	19,509 $561,000
Q2 2023 Jul 19, 2023	SELL	$36.12 - $41.79 $68,772 - $79,568	-1,904 Reduced 6.57%	27,064 $992,000
Q1 2023 Apr 17, 2023	BUY	$39.39 - $51.28 $76,771 - $99,944	1,949 Added 7.21%	28,968 $1.18 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $121,701 - $158,867	-2,915 Reduced 9.74%	27,019 $1.38 Million
Q3 2022 Oct 13, 2022	SELL	$43.76 - $53.42 $21,923 - $26,763	-501 Reduced 1.65%	29,934 $1.31 Million
Q2 2022 Jul 11, 2022	BUY	$46.53 - $55.17 $491,356 - $582,595	10,560 Added 53.13%	30,435 $1.6 Million
Q4 2021 Jan 21, 2022	SELL	$41.32 - $61.25 $51,691 - $76,623	-1,251 Reduced 5.92%	19,875 $1.17 Million
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $7,850 - $10,084	-200 Reduced 0.94%	21,126 $909,000
Q2 2021 Jul 14, 2021	SELL	$35.91 - $40.68 $287 - $325	-8 Reduced 0.04%	21,326 $835,000
Q1 2021 Apr 15, 2021	SELL	$33.49 - $37.77 $502 - $566	-15 Reduced 0.07%	21,334 $773,000
Q4 2020 Jan 12, 2021	BUY	$33.47 - $42.56 $33 - $42	1 Added 0.0%	21,349 $786,000
Q3 2020 Nov 05, 2020	SELL	$31.75 - $37.25 $31 - $37	-1 Reduced -0.0%	21,348 $784,000
Q2 2020 Jul 09, 2020	SELL	$30.12 - $36.54 $43,402 - $52,654	-1,441 Reduced 6.32%	21,349 $698,000
Q1 2020 Apr 22, 2020	SELL	$27.03 - $38.62 $18,921 - $27,034	-700 Reduced 2.98%	22,790 $744,000
Q4 2019 Jan 28, 2020	BUY	$32.92 - $37.36 $773,290 - $877,586	23,490 New	23,490 $920,000

Others Institutions Holding PFE

# of Institutions

3,365

Shares Held

3.57B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $124B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benchmark Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Benchmark Wealth Management, LLC with notifications on news.

Account

Benchmark Wealth Management, LLC Pfizer Inc Transaction History